Clinical trial
APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO)
NCT03615235 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO)
- Lead sponsor
- Wake Forest University Health Sciences
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- March 21, 2019
- Completion date
- May 30, 2027
- Enrollment
- 5,000 (estimated)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.
kidney disease, chronic, kidney diseases, kidney failure